blog.crownbio.comCrown Bioscience Blog

img height="1" width="1" src="https://www.facebook.com/tr?id=1582471781774081ev=PageView noscript=1" Contact Us Databases CrownLink US Tel: +1 858 622 2900 UK Tel: +44 870 242 2900 All Contact Information Services Therapeutic Areas Oncology In Vitro Services 2D Cell Lines and Panels PDX-Derived Cell Lines: Prime Panel ™ Organoids Organoid and Immune Cell Co-Culture Omni Screen ™ High Content Imaging Services 3D Ex Vivo Patient Tissue Platform 3D Patient-Derived Swelling Assay for Cystic Fibrosis In Vivo Services Patient-Derived Xenograft Models CDX Models Immuno-oncology In Vitro Services In Vivo Models CDX Models Syngeneic Models Humanized Models Mi Xeno ™ Cystopathic Diseases High Content Imaging Services Cyst Swelling Assay for ADPKD 3D Patient-Derived Swelling Assay for Cystic Fibrosis Model Systems In Vitro 2D Cell Lines and Panels PDX-Derived Cell Lines: Prime Panel ™ 2D Hu Cell ™ CRISPR/Cas9 Organoids Organoid and Immune Cell Co-Culture In Vitro High Quality Imaging Ex Vivo Patient Tissue Platform High Content Imaging Services 3D Ex Vivo Patient Tissue Platform 3D Patient-Derived Swelling Assay for Cystic Fibrosis In Vivo Patient-Derived Xenograft Models Cell Line Derived Xenograft Models Syngeneic Tumor Models Humanized Models Mi Xeno ™ GEMMs Tumor Homograft (Mu Prime ™ ) Orthotopic and Bioluminescent Models Immune Mediated Inflammatory Disease Models Diabetes IBD MS Models NASH Peritonitis Models Rheumatoid Arthritis Systemic Lupus Erythematosus Technologies Bioinformatics Crown Syn ™ Service Cell Line and Biosample Authentication Mouse I/O RNA-Seq Panel Biomarker Analysis Clinical Chemistry Services Cytokine & Chemokine Profiling Flow Cytometry Digital Pathology Tumor Tissue Miscroarray Rare Cell Analysis Mass Spectrometry-based Proteomics 4D-DIA Quantitative Proteomics 4D Phosphoproteomics CRISPR/Cas9 Genomics Standard Genomics Services Next Generation Sequencing Services Cell Line Authentication (CLA) with Deep Sequencing Mouse I/O RNA-Seq Panel NGS Data Analysis In Vitro High Content Imaging Ex Vivo Patient Tissue Platform High Content Imaging Services 3D Ex Vivo Patient Tissue Platform 3D Patient-Derived Swelling Assay for Cystic Fibrosis Mass Spectrometry-based Proteomics Service Type Biomarker Discovery Biomarkers of Response: Hu Mark ™ Biomarker Discovery and Companion Diagnostics Mouse Clinical Trials: Hu Trial ™ Signatures of Response: Hu Signature ™ DMPK Services Laboratory Services Genomics and Transcriptomics Standard Genomics Services Advanced Genomics and NGS Mouse I/O RNA-Seq Panel Cell Line Authentication with Deep Sequencing NGS data analysis Microbiome Sequencing Spatial Biology and Digital Pathology Digital Pathology Rare Cell Analysis High Content Imaging 3D Ex Vivo Patient Tissue Platform 3D Patient-Derived Swelling Assay for Cystic Fibrosis Rare Cell Analysis Tumor Tissue Microarray Immune Monitoring RNA sequencing Mouse I/O RNA-Seq panel Flow Cytometry Cytokine and chemokine profiling Digital Pathology Tumor Tissue Miscroarray ELISA and Multiplex Immunoassays Bioanalytical Services DMPK and Bioanalytical Services Flow Cytometry Cytokine and Chemokine Profiling Biofluid Test NanoString Spatial Multiomics Profiling Pharmacology and Bioanalytical Services Rodent Immuno-Safety Models Safety Pharmacology Studies Structural Biology Target Validation Screens Omni Screen ™ Mu Screen ™ Toxicology Efficacy TestingOur Company Our Purpose Our Responsibility Leadership Team News & Events Careers Our Science Publications Resources Blog Start Your Study Now Blog 2 minute read Cell Line Services FAQ May 2, 2024 4 minute read FAQ: Insights into Compliant Large-Scale Cell Line Screening Solutions April 18, 2024 3 minute read OrganoidXplore™: Routine and Rapid Compound Testing in a Large Panel of Organoids April 15, 2024 11 minute read A Technical FAQ Guide to Oncology Drug Screening Using Innovative Organoid Technology and Biomarker Analysis January 19, 2024 3 minute read Revolutionizing Cancer Drug Combination Discovery with AI: Introducing SynAI January 9, 2024 5 minute read Exploring the Future of Drug Combinations: A Deep Dive into In Vivo Synergy Research in Mouse Tumor Models November 21, 2023 4 minute read Fatty Acid Degradation (FAD) Subtypes of HCC PDX Models Accurately Recapitulate Anti-Cancer Drug Sensitivity in Patients November 17, 2023 5 minute read PDOs, PDXOs, PDOXs or PDXs? Selecting the Best Model to Progress Your Patient-Centric Research October 30, 2023 4 minute read Publication Spotlight: DSP vs. Visium: A Comparative Study in Spatial Transcriptomics for Cancer Research October 30, 2023 4 minute read A Novel Pancreatic Cancer Early Diagnostic Technology September 13, 2023 View Older Posts Search our Blog Categories ADCs Biomarkers Bladder Cancer Blood Cancer Breast Cancer Cancer Stem Cells CDX models Cell Lines Clinical Trials Colorectal Cancer Diagnostics DNA Damage Response Esophageal Cancer GEMM Models Glioblastoma Imaging Immuno-oncology Liver Cancer Metastasis NGS Head and Neck Cancer Oncogenes Oncolytic Viruses Organoids Ovarian Cancer Pancreatic Cancer PARP Inhibitors PDX Models PDXO Models Pediatric Cancer RAS proteins Sequencing Skin Cancer Stomach Cancer Syngeneic Models Tumor HomograftOur Company Our Purpose Our Responsibility Leadership News & Events Our Services Therapeutic Areas Model Systems Technologies Service Type Resources Blog Publications Factsheets White Papers Ebooks Webinars Platforms Onco Express™ Xeno Base ® Mu Base ® Hu Base™ Organoid Base™ Crown Link™ Talk To Us sales@crownbio.com +1 858 381 3547 Contact Us Distributors LinkedIn X © 2024 Crown Bioscience. All Rights Reserved. Privacy Policy . Manage Privacy Preferences © 2024 Crown Bioscience. All Rights Reserved. Privacy Policy 2024-05-09...